Loading...

We've got a brand new version of Simply Wall St! Try it out

Eurazeo

DB:EUQ
Snowflake Description

Established dividend payer and good value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
EUQ
DB
€5B
Market Cap
  1. Home
  2. DE
  3. Diversified Financials
Company description

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, leveraged buyouts, and buyins of a private company, and investments in mid-market and listed public companies. The last earnings update was 52 days ago. More info.


Add to Portfolio Compare Print
  • Eurazeo is a fund or ETF! Currently our data availability for these is poor, we only recommend using them as part of a portfolio.
EUQ Share Price and Events
7 Day Returns
3.5%
DB:EUQ
5%
DE Diversified Financial
2.8%
DE Market
1 Year Returns
11.3%
DB:EUQ
1.4%
DE Diversified Financial
3%
DE Market
EUQ Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Eurazeo (EUQ) 3.5% 6.8% 12.3% 11.3% - 91.3%
DE Diversified Financial 5% 7.8% -5% 1.4% 75.8% 333.7%
DE Market 2.8% 0.2% 1.3% 3% 8% 23.6%
1 Year Return vs Industry and Market
  • EUQ outperformed the Diversified Financial industry which returned 1.4% over the past year.
  • EUQ outperformed the Market in Germany which returned 3% over the past year.
Price Volatility
EUQ
Industry
5yr Volatility vs Market
Related Companies

Value

 Is Eurazeo undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Eurazeo to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Eurazeo.

DB:EUQ Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Excess Returns Model
Stable EPS Weighted future Return on Equity estimates from 5 analysts.
= Stable Book Value * Return on Equity
= €75.13 * 7.3%
€5.45
Book Value of Equity per Share Weighted future Book Value estimates from 3 analysts. €75.13
Discount Rate (Cost of Equity) See below 5.9%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:EUQ
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6.7%
Diversified Financial Unlevered Beta Simply Wall St/ S&P Global 0.72
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.72 (1 + (1- 33%) (81.31%))
0.859
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.86
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (0.859 * 6.65%)
5.94%

Discounted Cash Flow Calculation for DB:EUQ using Excess Returns Model Model

The calculations below outline how an intrinsic value for Eurazeo is arrived at using the Excess Return Model. This approach is used for finance firms where free cash flow is difficult to estimate.

In the Excess Return Model the value of a firm can be written as the sum of capital invested currently in the firm and the present value of excess returns that the firm expects to make in the future.

The model is sensitive to the Return on Equity of the company versus the Cost of Equity, how these are calculated is detailed below the main calculation.

Note the calculations below are per share.

See our documentation to learn about this calculation.

DB:EUQ Value of Excess Returns
Calculation Result
Excess Returns = (Stable Return on equity – Cost of equity) (Book Value of Equity per share)
= (7.3% – 5.94%) * €75.13)
€0.99
Terminal Value of Excess Returns = Excess Returns / (Cost of Equity - Expected Growth Rate)
= €0.99 / (5.94% - 0.23%)
€17.27
Value of Equity = Book Value per share + Terminal Value of Excess Returns
= €75.13 + €17.27
€92.41
DB:EUQ Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:EUQ represents 1.00146x of ENXTPA:RF
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
1.00146x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (EUR) x Listing Adjustment Factor
= € 92.41 x 1.00146
€92.54
Value per share (EUR) From above. €92.54
Current discount Discount to share price of €68.70
= -1 x (€68.70 - €92.54) / €92.54
25.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Eurazeo is available for.
Intrinsic value
26%
Share price is €68.7 vs Future cash flow value of €92.54
Current Discount Checks
For Eurazeo to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Eurazeo's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Eurazeo's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Eurazeo's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Eurazeo's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:EUQ PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in EUR €3.74
ENXTPA:RF Share Price ** ENXTPA (2019-10-11) in EUR €68.6
Germany Diversified Financial Industry PE Ratio Median Figure of 6 Publicly-Listed Diversified Financial Companies 27.82x
Germany Market PE Ratio Median Figure of 417 Publicly-Listed Companies 19.72x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Eurazeo.

DB:EUQ PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ENXTPA:RF Share Price ÷ EPS (both in EUR)

= 68.6 ÷ 3.74

18.32x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Eurazeo is good value based on earnings compared to the DE Diversified Financial industry average.
  • Eurazeo is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does Eurazeo's expected growth come at a high price?
Raw Data
DB:EUQ PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 18.32x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts
9.4%per year
Europe Diversified Financial Industry PEG Ratio Median Figure of 13 Publicly-Listed Diversified Financial Companies 1.81x
Germany Market PEG Ratio Median Figure of 265 Publicly-Listed Companies 1.39x

*Line of best fit is calculated by linear regression .

DB:EUQ PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 18.32x ÷ 9.4%

1.95x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Eurazeo is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Eurazeo's assets?
Raw Data
DB:EUQ PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in EUR €66.65
ENXTPA:RF Share Price * ENXTPA (2019-10-11) in EUR €68.6
Germany Diversified Financial Industry PB Ratio Median Figure of 9 Publicly-Listed Diversified Financial Companies 3.77x
Germany Market PB Ratio Median Figure of 598 Publicly-Listed Companies 1.74x
DB:EUQ PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ENXTPA:RF Share Price ÷ Book Value per Share (both in EUR)

= 68.6 ÷ 66.65

1.03x

* Primary Listing of Eurazeo.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Eurazeo is good value based on assets compared to the DE Diversified Financial industry average.
X
Value checks
We assess Eurazeo's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Diversified Financial industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Diversified Financial industry average (and greater than 0)? (1 check)
  5. Eurazeo has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Eurazeo expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
9.4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Eurazeo expected to grow at an attractive rate?
  • Eurazeo's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Eurazeo's earnings growth is positive but not above the Germany market average.
  • Eurazeo's revenue growth is positive but not above the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:EUQ Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:EUQ Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts 9.4%
DB:EUQ Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 5 Analysts 4.5%
Germany Diversified Financial Industry Earnings Growth Rate Market Cap Weighted Average 17.3%
Europe Diversified Financial Industry Revenue Growth Rate Market Cap Weighted Average 0.6%
Germany Market Earnings Growth Rate Market Cap Weighted Average 12.8%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:EUQ Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:EUQ Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 511
2021-12-31 5,197 540 446 3
2020-12-31 4,811 484 430 3
2019-12-31 4,400 414 397 2
2019-10-13
DB:EUQ Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-06-30 5,106 338 277
2019-03-31 5,013 290 286
2018-12-31 4,920 242 295
2018-09-30 4,795 184 397
2018-06-30 4,671 125 499
2018-03-31 4,344 161 490
2017-12-31 4,017 196 481
2017-09-30 4,026 177 552
2017-06-30 4,036 158 624
2017-03-31 3,522 148 575
2016-12-31 3,009 138 525
2016-09-30 3,097 302

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Eurazeo's earnings are expected to grow by 9.4% yearly, however this is not considered high growth (20% yearly).
  • Eurazeo's revenue is expected to grow by 4.5% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:EUQ Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below

All data from Eurazeo Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:EUQ Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31
2021-12-31 5.90 7.42 4.70 4.00
2020-12-31 5.75 7.90 4.18 5.00
2019-12-31 5.35 7.58 3.62 5.00
2019-10-13
DB:EUQ Past Financials Data
Date (Data in EUR Millions) EPS *
2019-06-30 3.74
2019-03-31 3.84
2018-12-31 3.94
2018-09-30 5.30
2018-06-30 6.66
2018-03-31 6.54
2017-12-31 6.41
2017-09-30 7.28
2017-06-30 8.13
2017-03-31 7.39
2016-12-31 6.67
2016-09-30 3.89

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Eurazeo is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Eurazeo's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Eurazeo has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Eurazeo performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Eurazeo's growth in the last year to its industry (Diversified Financial).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Eurazeo's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • Eurazeo's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Eurazeo's 1-year earnings growth is negative, it can't be compared to the Europe Diversified Financial industry average.
Earnings and Revenue History
Eurazeo's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Eurazeo Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:EUQ Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 5,105.82 276.60 1,938.92
2019-03-31 5,012.69 285.85 1,898.71
2018-12-31 4,919.56 295.10 1,858.51
2018-09-30 4,795.20 396.83 1,785.30
2018-06-30 4,670.89 498.55 1,712.09
2018-03-31 4,343.70 489.85 1,605.00
2017-12-31 4,016.52 481.15 1,497.90
2017-09-30 4,026.17 552.48 1,421.13
2017-06-30 4,035.82 623.82 1,344.35
2017-03-31 3,522.32 574.58 1,161.10
2016-12-31 3,008.82 525.34 977.84
2016-09-30 3,097.42 302.43 1,299.45
2016-06-30 1,388.77 78.98 583.47
2016-03-31 2,588.15 677.76 810.53
2015-12-31 3,787.52 1,276.55 1,037.59
2015-09-30 3,721.05 1,275.89 943.93
2015-06-30 5,451.83 1,275.78 1,887.86
2015-03-31 4,784.71 593.40 2,000.80
2014-12-31 4,117.59 -88.98 2,113.74
2014-09-30 4,254.60 25.20 2,077.39
2014-06-30 4,391.62 139.37 2,041.05
2014-03-31 4,817.14 350.16 2,060.27
2013-12-31 5,242.65 560.95 2,079.50
2013-09-30 5,145.64 408.92 2,076.02
2013-06-30 5,048.63 256.88 2,072.53
2013-03-31 4,720.56 29.17 2,072.59
2012-12-31 4,392.48 -198.54 2,072.65

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Eurazeo has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Eurazeo used its assets less efficiently than the DE Diversified Financial industry average last year based on Return on Assets.
  • Eurazeo has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Eurazeo's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Diversified Financial industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Eurazeo has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Eurazeo's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Eurazeo's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Eurazeo is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Eurazeo's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Eurazeo's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Eurazeo Company Filings, last reported 3 months ago.

DB:EUQ Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 6,688.37 3,603.90 1,341.72
2019-03-31 6,688.37 3,603.90 1,341.72
2018-12-31 6,294.42 3,420.51 990.00
2018-09-30 6,294.42 3,420.51 990.00
2018-06-30 6,360.89 3,359.09 816.60
2018-03-31 6,360.89 3,359.09 816.60
2017-12-31 5,996.78 3,305.08 926.64
2017-09-30 5,996.78 3,305.08 926.64
2017-06-30 5,235.14 2,588.28 782.01
2017-03-31 5,235.14 2,588.28 782.01
2016-12-31 5,235.69 3,114.78 1,627.64
2016-09-30 5,235.69 3,114.78 1,627.64
2016-06-30 4,758.04 2,804.90 940.80
2016-03-31 4,758.04 2,804.90 940.80
2015-12-31 4,747.39 1,603.35 1,298.61
2015-09-30 4,747.39 1,603.35 1,298.61
2015-06-30 4,919.83 1,566.77 1,717.75
2015-03-31 4,919.83 1,566.77 1,717.75
2014-12-31 3,522.50 5,660.87 1,020.85
2014-09-30 3,522.50 5,660.87 1,020.85
2014-06-30 3,375.95 5,479.66 1,081.30
2014-03-31 3,375.95 5,479.66 1,081.30
2013-12-31 3,445.79 4,964.20 1,319.73
2013-09-30 3,445.79 4,964.20 1,319.73
2013-06-30 3,392.25 5,857.99 854.55
2013-03-31 3,392.25 5,857.99 854.55
2012-12-31 3,298.95 6,770.01 659.56
  • Eurazeo's level of debt (53.9%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (162.3% vs 53.9% today).
  • Debt is not well covered by operating cash flow (9.4%, less than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 3.8x coverage).
X
Financial health checks
We assess Eurazeo's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Eurazeo has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Eurazeo's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.74%
Current annual income from Eurazeo dividends. Estimated to be 1.93% next year.
If you bought €2,000 of Eurazeo shares you are expected to receive €35 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Eurazeo's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.46%).
  • Eurazeo's dividend is below the markets top 25% of dividend payers in Germany (3.86%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:EUQ Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
Europe Diversified Financial Industry Average Dividend Yield Market Cap Weighted Average of 32 Stocks 3.2%
Germany Market Average Dividend Yield Market Cap Weighted Average of 337 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.7%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:EUQ Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2022-12-31 1.45 1.00
2021-12-31 1.40 5.00
2020-12-31 1.33 6.00
2019-12-31 1.27 8.00
2019-10-13
DB:EUQ Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2019-03-21 1.191 1.894
2018-03-21 1.134 1.802
2017-05-11 1.037 1.563
2016-04-11 0.987 2.035
2016-03-16 0.987 2.034
2015-05-06 0.940 1.936
2014-05-07 0.896 1.956
2013-04-15 0.853 2.277
2012-05-14 0.812 3.190
2011-04-19 0.774 3.098
2011-03-25 0.774 2.150
2010-03-22 0.737 2.240
2009-03-31 0.737 3.161

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Eurazeo's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (3.1x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (4.5x coverage).
X
Income/ dividend checks
We assess Eurazeo's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.7%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Eurazeo afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Eurazeo has a total score of 5/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Eurazeo's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Virginie Sarah Morgon
COMPENSATION €4,440,937
AGE 50
TENURE AS CEO 1.6 years
CEO Bio

Ms. Virginie Sarah Sandrine Morgon serves as Director at Moncler S.p.A. since April 2019. She serves as the President and Chief Executive Officer of Eurazeo North America Inc. (USA). Ms. Morgon has been the Chief Executive officer of Eurazeo SA (Eurazeo SE) since March 19, 2018 and has also been its Member of Management Board since January 22, 2008. She served as Deputy Chief Executive Officer at Eurazeo SA from March 2014 to March 18, 2018. Ms. Morgon co-leads the investment team. She supervises deal flow, communication, the NAV and fundraising. She has been with Eurazeo since 2008 and served as its Chief Investment Officer since 2011. She has been Chairwoman of the Management Board at Eurazeo since March 19, 2018. Ms. Morgon has accelerated Eurazeo’s diversification and growth across investment strategies and geographies, transforming Eurazeo into a multi-strategy international investment firm able to support companies across size and scale, from venture capital to large cap. She oversees a team focusing on mid-market investments in the consumer products and business services sectors in the U.S. She served as the Managing Director at Apcoa Group GmbH. She serves as the Chief Executive Officer/Managing Director at LH Apcoa. She serves as a Member of Supervisory Board of Eurazeo PME and previously served as the Chairwoman of Supervisory Board. She also serves on the Board of Directors of Desigual and is an independent Board member of L'Oreal. Ms. Morgon serves as the Chairwoman of the Supervisory Board of Eurazeo PME and Asmodee Holding. She was an Independent Member of Supervisory Board at Vivendi SA since June 24, 2014 until April 19, 2018. She serves as a Member of the Board of Directors at Club L-Femmes Forum. She serves as a member of Board of Directors of LT. Ms. Morgon has been an Independent Director of L'Oreal SA and L'Oreal USA, Inc. since April 26, 2013. She serves as a Director of Abasic Sl (Desigual, Spain). She serves as a Member of Supervisory Board at Grandir (Les Petits Chaperons Rouges investment), Trader Interactive LLC (USA) and Open Road Parent LLC (USA). She served as a Member of the Board of Directors of Open Road Parent LLC (USA) and Trader Interactive LLC (USA).She served as Manager of Euraleo (Italy) and Intercos SpA (Italy). She served as a Managing Director at Euraleo Srl (Italy). She was Managing Director at Intercos S.p.A. She worked for 16 years at Lazard where she advised international groups such as Air Liquide, Danone, Kingfisher, Publicis and Renault, in particular as an Investment Banker. She was the youngest Managing Senior Partner at Lazard from 2001 to 2007 and served as a Head of the European Consumer business in 2006. She advised a large number of French and international groups on mergers and acquisitions. She was a Partner at Compagnie Financière Lazard Frères SAS. She was a Senior Partner/Managing Partner at Lazard Frères & Cie. from 2000 to 2007. While at the firm, she served as the Head of the European food, retail and consumer goods sector. She established a privileged relationship with major groups such as Air Liquide, Danone, Publicis, Kingsfischer/Castorama and Kesa/Darty. She served as an Investment Banker and an Analyst from 1991 to 2000. Ms. Morgon started her career in 1991. Ms. Morgon served as Chairwoman of the Advisory Board and Supervisory Board at APCOA Parking AG. She served as the Chairman of the Board of Holdelis, Legendre Holding 44, Legendre Holding 45, Legendre Holding 46, Legendre Holding 33, Legendre Holding 47 and Legendre Holding 43. She served as the Chairman of Broletto 1 S.r.l. She served as the Chairman of the Advisory Board at Apcoa Parking Holdings GmbH. Ms. Morgon had been Vice Chairman of Moncler S.p.A. since 2011 until April 2019. She served as a Director at the Women's Forum for Economy & Society. She served as a Director of Women's Forum (WEFCOS). Ms. Morgon served as the Chairwoman of the B&B Hotels Group Supervisory Board. She served as the Chairman of the Supervisory Board of S.A. Elis and served as its Member of Supervisory Board since September 5, 2014 until June 15, 2016. She was Vice President of Paris at Human Rights Watch. She was a Director at AccorHotels. She served as a Chairwoman of the Supervisory Board at Groupe B&B Hotels. She served as Vice-Chairman of APCOA Parkings Holdings GmbH. She served as a Director of Accor S.A. from May 13, 2009 to May 2, 2016. She served as a Director of Sportswear Industries Srl. She served as a member on the Board of Directors at LT Participations. She served as a Director of Edenred SA from June 29, 2010 to March 6, 2013. Ms. Morgon has been regularly ranked on Fortune's Most Powerful Women International 50 list. Ms. Morgon holds an Master in Economics and Finance section from IEP (School of Higher Education for Political Studies), Paris, France in 1990 and a Masters in economics and management from the University of Bocconi from Milan, Italy in 1991. She holds MBA with Finance at Institut d'Etudes Politiques de Paris.

CEO Compensation
  • Virginie Sarah's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
  • Virginie Sarah's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Eurazeo management team in years:

1.6
Average Tenure
52.5
Average Age
  • The average tenure for the Eurazeo management team is less than 2 years, this suggests a new team.
Management Team

Virginie Sarah Morgon

TITLE
Chair of Executive Board & CEO
COMPENSATION
€4M
AGE
50
TENURE
1.6 yrs

Philippe Audouin

TITLE
CFO & Member of Executive Board
COMPENSATION
€2M
AGE
62

Nicolas Huet

TITLE
General Secretary & Member of the Executive Board
COMPENSATION
€980K
AGE
49
TENURE
1.6 yrs

Olivier Millet

TITLE
Member of the Executive Board
COMPENSATION
€1M
AGE
55
TENURE
1.6 yrs

Pierre Bernardin

TITLE
Head of Investor Relations
TENURE
0.1 yrs

Nathalie Trolez-Mazurier

TITLE
Deputy General Counsel of Securities & Compliance

Virginie Christnacht

TITLE
Head of Communications & Corporate Communication Director

Vincent Beguin

TITLE
Business Development Director
TENURE
1.8 yrs

Caroline Hadrbolec

TITLE
Chief Human Resources Officer

Laurent Guérineau

TITLE
Managing Director of Eurazeo Development
TENURE
3.1 yrs
Board of Directors Tenure

Average tenure and age of the Eurazeo board of directors in years:

10.4
Average Tenure
63
Average Age
  • The average tenure for the Eurazeo board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Michel David-Weill

TITLE
Chairman of Supervisory Board
COMPENSATION
€464K
AGE
87
TENURE
16.3 yrs

Olivier du Vignaux

TITLE
Vice Chairman of Supervisory Board
COMPENSATION
€67K
AGE
63

Jean-Charles Decaux

TITLE
Vice-Chairman of the Supervisory Board
COMPENSATION
€44K
AGE
50

Bruno Roger

TITLE
Honorary Chairman of the Supervisory Board
COMPENSATION
€555K
AGE
86

Erwann Ligne

TITLE
MD & Member of Executive Board of Eurazeo PME

Roland du de Montsaulnin

TITLE
Independent Member of Supervisory Board
COMPENSATION
€59K
AGE
79
TENURE
15.4 yrs

Anne Lalou

TITLE
Member of the Supervisory Board
COMPENSATION
€45K
AGE
56
TENURE
9.4 yrs

Anne Dias-Griffin

TITLE
Independent Member of Supervisory Board
COMPENSATION
€74K
AGE
49
TENURE
2.4 yrs

Patrick Sayer

TITLE
Member of Supervisory Board
COMPENSATION
€4M
AGE
62
TENURE
1.5 yrs

Jean-Pierre Richardson

TITLE
Non-Voting Board Member
COMPENSATION
€51K
AGE
80
TENURE
11.4 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Eurazeo's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Eurazeo has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, leveraged buyouts, and buyins of a private company, and investments in mid-market and listed public companies. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, personal care, household care, juvenile products, apparel, accessories, home, jewelry, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc.) It primarily invests in United States, France, Italy, and other European countries. The firm typically invests between $10 million and €800 million ($892.55 million) in companies with enterprise values of more than €150/200 million ($163.74 million/$218.30 million) and $7108.9 million. It limits each investment to less than 10 percent to 15 percent of its net asset value. The firm can also invest where its equity or quasi-equity stake is between €175 million ($195.25 million) and €800 million ($892.55 million). It prefers to acquire majority stakes in its portfolio companies. The firm may invest in public companies either taking the public company to private, and then doing a leveraged buyout or in the form of private investment in public equity (PIPE). The firm invests for a period of five to seven years. It exits its investment by sale to a manufacturer, sale to a financial investor, or through an IPO. Eurazeo SE was founded in 1969 and is based in Paris, France with additional offices in North America, Asia, Europe and South America.

Details
Name: Eurazeo SE
EUQ
Exchange: DB
Founded: 1969
€5,253,731,617
76,585,009
Website: http://www.eurazeo.com
Address: Eurazeo SE
1 rue Georges Berger,
Paris,
Ile-de-France, 75017,
France
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ENXTPA RF Ordinary Shares Euronext Paris FR EUR 02. Jan 1992
OTCPK EUZO.F Ordinary Shares Pink Sheets LLC US USD 02. Jan 1992
DB EUQ Ordinary Shares Deutsche Boerse AG DE EUR 02. Jan 1992
LSE 0HZC Ordinary Shares London Stock Exchange GB EUR 02. Jan 1992
BATS-CHIXE RFP Ordinary Shares BATS 'Chi-X Europe' GB EUR 02. Jan 1992
Number of employees
Current staff
Staff numbers
20,294
Eurazeo employees.
Industry
Multi-Sector Holdings
Diversified Financials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/10/13 22:31
End of day share price update: 2019/10/11 00:00
Last estimates confirmation: 2019/09/17
Last earnings filing: 2019/08/22
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.